LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Thursday reported a loss of $7.2 million in its third quarter.
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 22 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The drug developer posted revenue of $2.8 million in the period.
The company's shares closed at $1.63. A year ago, they were trading at $7.90.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRIS at https://www.zacks.com/ap/CRIS